Who is sponsoring NCT05523180?

NCT05523180 is sponsored by ResBiotic Nutrition, Inc..

What drugs are being tested in NCT05523180?

Interventions in NCT05523180: Probiotic, Placebo.

What condition does NCT05523180 study?

NCT05523180 studies Chronic Obstructive Pulmonary Disease, Non-cystic Fibrosis Bronchiectasis.

Is NCT05523180 still recruiting?

NCT05523180 is currently completed. Last updated 5 June 2024.

Last reviewed 2024-06-05 · How we verify

NCT05523180

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

A Study to Evaluate the Effect of Probiotic Supplement on Quality of Life

Completed NA Last updated 5 June 2024

What this trial tests

NA trial testing Probiotic in Chronic Obstructive Pulmonary Disease in 37 participants. Completed in 12 September 2023.

Timeline

1 September 2022

Primary endpoint
12 September 2023

12 September 2023

Quick facts

Lead sponsor	ResBiotic Nutrition, Inc.
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	other
Enrollment	37
Start date	1 September 2022
Primary completion	12 September 2023
Estimated completion	12 September 2023
Sites	2 locations across United States

Drugs / interventions tested

Probiotic
Placebo

Conditions studied

Chronic Obstructive Pulmonary Disease — all drugs for Chronic Obstructive Pulmonary Disease →
Non-cystic Fibrosis Bronchiectasis — all drugs for Non-cystic Fibrosis Bronchiectasis →

Sponsor

ResBiotic Nutrition, Inc.

Who can join

Adults 18 to 80, any sex, with Chronic Obstructive Pulmonary Disease or Non-cystic Fibrosis Bronchiectasis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aims to evaluate the impact of a specific oral probiotic blend on the quality of life of adults with respiratory conditions.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Double-Blind Randomized Placebo-Controlled Trial of a Lactobacillus Probiotic Blend in Chronic Obstructive Pulmonary Disease.
Nicola T, Wenger NM, Seidman K, Evans M, et al · · 2026 · PMID 41254308 · DOI 10.1007/s41030-025-00333-y
Double-Blind Randomized Placebo Controlled Trial of a<i>Lactobacillus</i>Probiotic Blend in Chronic Obstructive Pulmonary Disease
Nicola T, Wenger NM, Evans M, Yang Y, et al · · 2024 · DOI 10.1101/2024.10.02.24314795

Verify or expand the search:

Other trials of Probiotic

Trials testing the same drug.

NCT07529457 — Akk09 in Adults With Constipation · NA · not yet recruiting
NCT07507955 — Probiotics for Constipation Relief in Adults · NA · not yet recruiting
NCT07462481 — Probiotic Improve Constipation · NA · recruiting
NCT07511855 — Stress-buffering and Sleep Disturbance-resilient Effects of a Dual Bifidobacterium Longum Combination Under Short-term T · Phase 2 · not yet recruiting
NCT07474064 — Probiotics Combined With Targeted Therapy Plus Immunotherapy in Bladder-Preserving Setting for Patients With MIBC · Phase 2 · not yet recruiting

Other recruiting trials for Chronic Obstructive Pulmonary Disease

Currently open trials in the same condition.

NCT06749262 — Inclined Versus Standard Exercise for COPD Patients · NA · recruiting
NCT07406659 — Different Inspiratory Muscle Trainings in Patients With COPD · NA · recruiting
NCT07051707 — Evaluating the Safety and Efficacy of dNerva Lung Denervation System in Patients With COPD · NA · recruiting
NCT07418736 — A Phase II Study of CM326 in Subjects With Moderate to Severe Chronic Obstructive Pulmonary Disease · Phase 2 · recruiting
NCT07069829 — Study of Clinical and Patient-reported Outcomes in Adults With Moderate to Severe COPD Treated With Breztri/Trixeo · recruiting

Other ResBiotic Nutrition, Inc. trials

Trials by the same sponsor.

NCT05173168 — A Pilot Study to Assess the Safety Profile of resB® · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05523180 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by ResBiotic Nutrition, Inc.
Last refreshed: 5 June 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05523180.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing